• We gave a questionnaire to self-advocates who were attending a conference. The questionnaire asked them how they felt about the information they get with their medicine.
| INTRODUCTION
There are clear health disparities between people with learning disabilities and the general population (Emerson & Hatton, 2013; Heslop et al., 2014) , leading to concern among professionals about the health information they provide. People with learning disabilities are prescribed medication for psychological and medical conditions as well as for the reduction of challenging behaviour (Lewis, Lewis, Leake, King, & Lindemann, 2002) . They experience higher rates of adverse health conditions such as epilepsy and neurological disorders, gastrointestinal disorders and psychiatric conditions as well as higher levels of preventable health issues (Krahn, Hammond, & Turner, 2006) . Some of this disparity may be because they are not getting the correct information about medication, healthy living or self-screening (Krahn et al., 2006) , and furthermore they may experience poorer access to quality primary care due to lack of reasonable adjustments, which take into account people's needs (Alborz, McNally, & Glendinning, 2005; Balogh, Brownell, Ouellette-Kuntz, & Colantonio, 2010) .
It has been found that education level and cognitive functions such as memory and conceptualisation are related to medication compliance in psychiatric services (Jeste et al., 2003; Ruscher, De Wit, & Mazmanian, 1997) . Often, "health literacy" of patients is referred to as the problem (Wolf, Davis, Tilson, Bass, & Parker, 2006) ; however, it has been argued that this can be addressed by reducing the use of jargon and understanding the communication needs of patients (Shepard, 2016) .
In a review of the literature about medication/prescription information and the perspectives of people with learning disabilities, we found a small number of research studies. Among them were Arscott, Stenfert Kroese, and Dagnan (2000) , who interviewed 30 people with learning disabilities about their medication. They found that 70% of adults with learning disabilities took psychotropic medication, 66.7% took nonpsychotropic medication and 26.6% of their participants were prescribed four or more medications regularly. In terms of information, they found that their participants had limited knowledge about side effects, alternatives to the medicine they were taking and contraindications. Arscott et al. argue that people are not given enough information about their medicine, and that information is not accessible enough. Heslop, Folkes, and Rodgers (2005) found their participants to be similarly ill-informed. They interviewed 21 people with learning disabilities, their carers and prescribers. They found that few people were fully advised about why they were taking their medication and the potential adverse effects. Most of the information had been given to carers, who knew how to administer medicines but did not know why they had been prescribed or the implications. People felt that they had little or no choice about taking the medication. Heslop et al. recom- mended that prescribers spend time to explain key facts and provide accessible and up-to-date information which is tailored to the patient's needs, and that training should be provided for carers.
A key theme in the literature is that people were given inappropriate information not tailored to their needs. For example, a National Patient Safety Agency (2004) study with 45 participants with learning disabilities found that medication information was inaccessible; the participants in this study would have preferred information with pictures or in an audio format. People said that they often identified their tablets by colour, something that was flagged up in the report as potentially dangerous, as different pills can look similar to each other and a medication's appearance can change over time.
Research has found that people with learning disabilities also lack knowledge about psychotropic medications that they are prescribed.
For example, Strydom, Forster, Wilkie, Edwards, and Hall (2001) gave a questionnaire to 21 people with learning disabilities who were prescribed antipsychotic medication; 22% did not know why they were taking the medication, 48% could not read the label, 38% did not know any side effects, and 52% were not aware of any contraindications. Twenty people said they would have liked a readable leaflet. Similarly, Jubraj, Deakin, Mills, and Grimes (2016) explored people's experiences of pharmacies in a focus group with people with learning disabilities. They found that the focus group members in their study, despite regularly taking medicines, were unclear about why they needed them and how they helped. They explained that pharmacists often spoke to their parents or carers during consultations instead of them. All were unaware that they could ask the pharmacist themselves for information about their medicines. Group members said they would like the pharmacist to talk to them directly and give them more accessible information about their medicines.
This existing literature shows that people with learning disabilities are not getting enough information about their medication from either their GP or pharmacists. In particular, more information is needed about the function of the medicine as well as risk factors and contraindications. Furthermore, health professionals are not involving patients themselves in consultations enough, preferring to discuss with carers or family members. Health outcomes are better when patients take a more participatory role in decisions about their health (Trummer, Mueller, Nowak, Stidl, & Pelikan, 2006) , but without making sure that patients have the correct knowledge to make decisions, it is impossible to assume their consent to treatment.
Each of the studies outlined above focusses on a particular area of prescribing. None of the studies asks participants where they get the most helpful information from and what format they would prefer.
This research study aimed to explore these questions using a smallscale questionnaire study.
| POLICY
There are important national guidelines in the UK on how communication should occur with people with learning disabilities. The 1983
Mental Health Act makes it clear that people should be informed about side effects of medication as well as alternatives (see Mind, 2009 ). so what they are. This must be performed "proactively and opportunistically" using professional judgement. This may include using guidance questions to find out about any learning disability, as detailed in Glover and Emerson (2012) .
2.
Record: record those needs in a clear, unambiguous and standardised way in electronic and/or paper based record. Information needs should be recorded rather than impairment or condition.
3. Alert/flag/highlight: ensure that recorded needs are "highly visible" whenever the individual's record is accessed, and prompt for action.
4.
Share: include information about individuals' information or communication needs as part of existing data sharing processes (and in line with existing information governance frameworks).
5.
Act: take steps to ensure that individuals receive information which they can access and understand, and receive communication support if they need it.
Although this act only relates to England, it should be considered good practice for all health providers to follow this guidance. The Equality Act (UK) and the Accessible Information Standard make it clear that it is the responsibility of the organisation and its staff to make information understandable in order that patients make informed decisions about their care.
It is envisaged that the findings from the present study will be helpful to services when they are planning how to implement these policy goals, in terms of people's information requirements and the format of resources to use. The pictures were simple, line drawn black and white, depicting people and objects such as medicine bottles and pill blister packs.
| METHOD
This questionnaire was circulated to all self-advocates at the North West Self-Advocacy conference which was held in Blackpool in February 2016 and is organised by NWTDT and Pathways Associates.
The delegates were asked to complete the questionnaires alone or with support from their assistant or family members.
Fifty-eight questionnaires were returned. This represents approximately 48% of the 120 self-advocates who attended the conference.
This may have some relevance to the type of data obtained; perhaps only those who were above a particular threshold of literacy agreed to complete a questionnaire. The questionnaires were anonymous, no names were collected or recorded.
The results were organised into themes, with a frequency count to show how many responses reported the same issue. In the results section below, we use tables to show the frequency count and provide an example quote to illustrate the theme.
| RESULTS
From the questionnaire responses, it was clear that people had experience of visiting and obtaining medications from both GP surgeries and pharmacists. Most of the questionnaires were fully completed and people often provided multiple points in each section. Each of the following tables shows the groups of responses and the amount received.
Example comments from the completed questionnaires are provided.
Fifty-five per cent of people (n = 32) said that they got helpful information from their GP; Table 1 shows in more detail what information they received. Out of those who answered that the information was helpful, most of the information they received was instructional, such as when to take the medicine and for how long. Some of these participants reported that their GP took time to explain about the medicine and show them how to take it.
Overall 29% of participants (n = 17) said the information they received was not helpful. Table 2 shows the reasons people gave for this. The most frequent themes were that the information was not accessible to them and they were only given basic information. Some people reported that information was only given to their carer and they were not involved in the discussions. Table 3 shows what information people said they received from their pharmacist. Twenty-four per cent of respondents (n = 14) reported receiving no information at all. The information people reportedly received was instructional, such as dosage and when to take the medicine. Five respondents reported that the pharmacist gave information to their carer but not to them. Some people reported that the information was not accessible or was given verbally only. Table 4 shows all the suggestions that people gave for change, incorporating the answers to both questions: "What else could the doctor do to help you understand your medicine?" And "What other support would help people to understand their medicine?" Sixty-six per cent of people (n = 38) wanted an easy-read leaflet and 17% (n = 10) wanted pictures or diagrams. Seven per cent (n = 4) reported that they wanted information about side effects and risks so they could make a choice about different medicines. Some participants stated that they wanted their carers or family to be involved, but would prefer that the health professionals discussed the issues with them as the patient.
| DISCUSSION
The results of this study suggest that people are generally not receiving information that they can understand and retain. People were only being given basic information about when and how to take the medicine and not offered information about side effects or How to take the medicine 3 "Just to take my inhalers, brown one twice in the morning and night, blue one when I'm wheezing."
When to get next prescription 2 "They tell me when to pick my next prescription up and what they are for."
Showed me how to take it 2 "Showed how to use the medication. Tested condition for a while then diagnosed. Verbal." Dosage 2 "The information you are given is the sort of tablets they put you on and how many times a day to take them."
T A B L E 1 Helpful information received from GP contraindications. Participants had many recommendations about the information that would help them to understand how to take medications, such as easy-read leaflets and pictures/diagrams or videos. They also had advice about other things that health professionals could do, such as offer guidance on healthy living and alternative medications.
The participants often wanted their carers or family members to be informed about their medications, but a key theme from the results was that they wanted to be involved directly in the consultations. Alternatives to easy-read leaflets are visual or audio formats; however, some of our participants reported that they found it difficult to remember verbal information. Therefore, we propose that offering easy-read and pictorial information to take home along with signposts to other mediums (such as apps, DVDs etc.) should be combined with verbal information in a consultation that is tailored to the person. Adapted health information has a better chance of making an impact when it is tailored to an individual's individual requirements (Chinn & Homeyard, 2016) .
Further, it is important that the resources should be co-produced with people with learning disabilities who are more likely to have experienced the insufficiency of health information as described in this study and the wider literature (Ward & Townsley, 2005) . advised that rather than excluding people with learning disabilities from the resources available, carers and health professionals should assist them to use the resources and help them to align new knowledge with previous knowledge. This suggests that appointment windows should be extended in order that there is time to do this (Jubraj, Barnett, et al., 2016) .
We agree with Heslop et al. (2005) , who recommend that professionals have time to spend on key facts, having accessible information available which is kept up to date, and training about medication for carers.
Most of the participants in the current study did not recall receiving enough information about their medication, including side effects. It is possible that health professionals do not want to provide an overwhelming amount of information. McGrath (1999) reported that prescribers preferred two-way interactions focusing on the specific needs of the patient, rather than simply disseminating more and more information about the prescription. However, the prescribers in McGrath's study tended to weigh up the benefits No information given 2 "I just get a prescription."
T A B L E 2 Reasons why information given by GP is not helpful T A B L E 3 Information received from pharmacist

Response Frequency
No information 14
Paper Information Dosage 8
Inaccessible leaflet 8
When/how often to take medicine 7
Different names for the same medicine is confusing 2
How to store the medicine 1
Given a phone number 1
Face-to-face
Given verbal information 4
When to come back/how long medicine will last 3
How to take medicine 3 The question of who provides this information is an important consideration. In the present study, most of the people said they received information from their GP. People with learning disabilities are often invisible to pharmacists (Flood & Henman, 2010) as carers or staff often pick up the medications. However, some of our respondents pointed out that the GP and pharmacists talked to their carer or family member and not them, even when they were present. Participants in other studies also have commented on this (Jubraj, Deakin, et al., 2016; The Disability Partnership, 2016) . We argue that pharmacy consultations should be in-depth and tailored to the person's communication style and ability (Dickinson et al., 2013) . Furthermore, GPs, nurses and pharmacists should work together to share information about patients' requirements and provide person-centred care (Blasi, Kendall, & Spark, 2006) . Verbal explanations with no difficult words 9 "Any info in a verbal equivalent of easy-read, plain English would help."
T A B L E 4 Suggestions for change
Explain why I need to take it 8 "Easy-read and simple explanation (needs to be written down, I don't always get it when they just say it). What I need to take, when I need to take it and why I am taking it."
Explain how the medicine works Explain about alternative medicines 3 "Give me an easy-read information sheet: is there something else I can take instead?"
Other Regular reviews and health checks 5 "Your doctor could tell you why you need your medication. He could send you for a medical review and take blood tests."
Mobile alerts/special alarm as reminder/timetable 4 "Talk to you about it in words you understand and give you a clear timetable so you know when to see them!"
Label/container with space to write on 2 "Tell me why I'm taking it. Make sure the label on the bottle says how to take it. Saying 'as discussed' doesn't help."
The respondents in this study reported that they wanted access to resources that they could understand and refer back to. In terms of access to resources, there have been a number of movements towards providing assistance with reasonable adjustments. For example:
The Learning Disabilities Observatory surveyed NHS trusts to
find out what is provided (Hatton, Roberts, & Baines, 2011) and from this, Turner and Robinson (2011) produced resources for professionals and service users about their right to expect reasonable adjustments. 
The organisation
5.
Others have developed decision-making tools for patients (The Disability Partnership, 2016) and communication aid resources which can be used two-way to discuss health information (Dodd & Brunker, 1999; Heslop, Folkes, & Rodgers, 2004) .
6.
Creative strategies have been devised to improve two-way communication such as the use of Health Passports (Disability Partnership, 2016), training service users to evaluate and review health services (Campbell & Martin, 2010) and employing service users to train pharmacists in how to communicate effectively (Donnelly, 2013) .
7. Jubraj, Deakin, et al. (2016) recommend the use of "My Medication
Passport" as focus groups in their study felt that this was a useful tool.
These resources are all designed to help with accessible information provision to people with learning disabilities. Despite this wealth of available resources, the participants in the present study were not getting the information they needed. This could be due to lack of knowledge or awareness of the resources, or the absence of a centralised, approved space where they are stored. Further, most of the easy-read information available does not concern specific medications and this is what the present study highlights as a crucial gap.
There are limitations to this study. It should be noted that the sample of self-advocates is not representative of people with learning disabilities; it is a convenience sample only. A sample taken from a group of self-advocates may have a higher ability and/or skill level than a sample of people with learning disabilities taken from the general population. Further, the people who chose to complete a questionnaire may have been those with higher literacy levels than others at the conference. Therefore, the results of this study should not be taken as generaliseable.
| CONCLUSION
A key finding of this study, consistent with other studies, is that health professionals tend to talk to carers or family members rather than the individual themselves. This could be due to lack of skills and knowledge and could be addressed through training for GPs and pharmacists on eliciting and providing information to individuals with communication needs. The diverse responses and recommendations from our respondents demonstrate the wide range of accessibility requirements; health professionals should develop skills and systems to tailor their information to the person and be willing to provide information in more than one format (such as verbal and easy-read).
Another key finding was that not all professionals spend the time to explain conditions and medications to people with learning disabilities. We recommend that extra appointment time should be allotted to working with people with accessibility needs, that professionals should spend the time early on to get to know the individual and their requirements, and this will compensate in later appointments.
This study also demonstrates the lack of knowledge about available resources for people with learning disabilities. Future research should focus on the implications of providing inaccessible health information, in particular the issue of polypharmacy and the difficulties of retaining information about multiple medications. Future research could explore the viability of providing a centralised system, connected electronically to GP and pharmacist information systems. This sort of resource, along with person-centred consultations with both GP and pharmacy staff, would allow greater access to the information people need to make informed decisions about their medications, and better knowledge of how to use them.
